Diana DeGette
Showing 1–2 of 2 transcripts.
- Milken Institute53 min
Health Care of the Future | Future of Health Summit 2024
Michael Milken, Alex Azar, Buddy Carter, Diana DeGette, Renee Wegrzyn
The event detailed how ARPA-H and legislative initiatives like "Cures 2.0" are addressing systemic healthcare challenges by funding high-risk biomedical innovations and ensuring pharmaceutical independence. Key figures including Rep. Diana DeGette and Rep. Chris Carter highlighted strategies to reform Medicare Advantage payment models and repatriate drug manufacturing to counter supply chain vulnerabilities. The panel concluded with a call for increased federal investment in translational science and a broader call for business leaders to enter government to sustain the pace of medical breakthroughs.
- Milken Institute1h 12m
The Future of Health 2018
Tanisha Carino, Francis Collins, Diana DeGette, Jim Yong Kim, Michael Milken, Rajiv Shah
At a recent biomedical and economic conference, leaders discussed the transformative $3 billion 21st Century Cures Act and the ambitious "All of Us" program, which aims to recruit one million participants to generate personalized genomic and health data while addressing the opioid crisis through standardized research. Complementing these health initiatives, the World Bank introduced a Human Capital Index to rank nations on health and education outcomes, urging G20 leaders and investors to fund early development and infrastructure to mitigate global risks like automation-driven inequality and obesity-related economic burdens. These strategies collectively emphasize that sustained economic growth and stability depend on treating human capital investment as a critical driver of national sovereignty and future market resilience.